-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Integrated Biopharma Inc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q3 2015 to Q3 2024.
- Integrated Biopharma Inc Depreciation, Depletion and Amortization for the quarter ending September 30, 2024 was $88K, a 14.3% increase year-over-year.
- Integrated Biopharma Inc annual Depreciation, Depletion and Amortization for 2024 was $319K, a 9.12% decline from 2023.
- Integrated Biopharma Inc annual Depreciation, Depletion and Amortization for 2023 was $351K, a 4.46% increase from 2022.
- Integrated Biopharma Inc annual Depreciation, Depletion and Amortization for 2022 was $336K, a 0.3% decline from 2021.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)